All Stories

  1. Diagnostic Performance of 18F-FDG PET/CT in Infectious and Inflammatory Diseases according to Published Meta-Analyses
  2. Prognostic Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Anal Squamous Cell Carcinoma: A Systematic Review and a Meta-Analysis
  3. Recent Developments of 18F-FET PET in Neuro-oncology
  4. Ectopic Mature Cerebral Tissue in the Nasal Cavity Incidentally Detected by 18F-FDG PET/CT
  5. Squamous Cell Carcinoma of the Tonsil Incidentally Detected by 18F-Choline PET/CT
  6. A Rare Case of Metastatic Clear Cell Carcinoma of the Müllerian System Originating From the Peritoneum Assessed by 18F-FDG PET/CT
  7. An Unusual Case of Diffuse Large B-Cell Lymphoma Involving the Vulva Evaluated by 18F-FDG PET/CT
  8. Incidental 11C-Choline PET/CT Uptake Due to Esophageal Carcinoma in a Patient Studied for Prostate Cancer
  9. A rare case of thyroid paraganglioma detected by 18F-FDG PET/CT
  10. Multifocal Epithelioid Hemangioendothelioma of the Lower Limbs Detected by 18F-FDG PET/MRI
  11. Current Role and Future Perspectives of Radioiodinated MIBG in the Evaluation of Dementia with Lewy Bodies
  12. Role of isotope scan, including positron emission tomography/computed tomography, in nodular goitre
  13. Diagnostic Performance of Dedicated Positron Emission Mammography Using Fluorine-18-Fluorodeoxyglucose in Women With Suspicious Breast Lesions: A Meta-analysis
  14. Functional Imaging Evaluation in the Detection, Diagnosis, and Histologic Differentiation of Pulmonary Neuroendocrine Tumors
  15. An Unusual Orbital Localization of Wegener Granulomatosis Detected by 18F-FDG PET/CT
  16. A Rare Case of Synchronous Fetal Type Adenocarcinoma and Mucinous Adenocarcinoma of the Lung Evaluated by 18F-FDG PET/CT
  17. The role of fluorine-18-fluorodeoxyglucose positron emission tomography in evaluating the response to tyrosine-kinase inhibitors in patients with metastatic primary renal cell carcinoma
  18. A Rare Case of Mucinous Cystadenoma of the Lung Mimicking Malignancy at 18F-FDG PET/CT
  19. Determining axillary concordance rate for different injection locations in sentinel node mapping of breast cancer: how ambitious can we get?
  20. Usefulness of 11C-Methionine Positron Emission Tomography in Differential Diagnosis between Recurrent Tumours and Radiation Necro-sis in Patients with Glioma: An Overview
  21. PET/CT assessment of neuroendocrine tumors of the lung with special emphasis on bronchial carcinoids
  22. A Rare Case of Primary Pulmonary Epithelioid Angiosarcoma Detected by 18F-FDG PET/CT
  23. The Role of 18F-FDG-PET and PET/CT in Patients with Sarcoidosis
  24. A Rare Case of Solitary Fibrous Tumor of the Adrenal Gland Detected by 18F-FDG PET/CT
  25. 18F-FDG uptake as a prognostic variable in primary differentiated thyroid cancer incidentally detected by PET/CT: a multicentre study
  26. Prevalence and malignancy risk of focal colorectal incidental uptake detected by 18F-FDG-PET or PET/CT: a meta-analysis
  27. Is it time to validate the prognostic role of F-18-FDG PET/CT scan in thymic epithelial tumors?
  28. Left atrial metastasis of Hürthle-cell thyroid carcinoma mimicking myxoma
  29. A Thyroid Incidentaloma Detected by 18F-Choline PET/CT
  30. Efficacy of Different Protocols of Radioiodine Therapy for Treatment of Toxic Nodular Goiter: Systematic Review and Meta-Analysis of the Literature
  31. An Unusual Case of Extramedullary Plasmacytoma of the Hypopharynx Detected by 18F-FDG PET/CT
  32. Colorectal Carcinoma With Bone Metastases Detected by 18F-Choline PET/CT
  33. Risk stratification and prognosis determination using 18F-FDG PET imaging in endometrial cancer patients: A systematic review and meta-analysis
  34. A Pulmonary Metastasis of a Cystosarcoma Phyllodes of the Breast Detected by 18F-FDG PET/CT
  35. Evolving role of PET/CT with different tracers in the evaluation of pulmonary neuroendocrine tumours
  36. An Unusual Case of Extraskeletal Retroperitoneal Osteosarcoma Incidentally Detected by 18F-FDG PET/CT
  37. Axillary concordance between superficial and deep sentinel node mapping material injections in breast cancer patients: systematic review and meta-analysis of the literature
  38. Rare sinonasal small cell neuroendocrine carcinoma evaluated by F-18-FDG PET/MRI
  39. Usefulness of 18F-FDG PET/CT in a Rare Case of Malignant Pseudothyroiditis
  40. A Rare Case of Primary Pulmonary Synovial Sarcoma in a Pediatric Patient Evaluated by 18F-FDG PET/CT
  41. Positron Emission Tomography/Computed Tomography for Diagnosis of Prosthetic Valve Endocarditis
  42. Unstimulated Highly Sensitive Thyroglobulin in Follow-up of Differentiated Thyroid Cancer Patients: A Meta-Analysis
  43. Comparison Between Myocardial Sympathetic and Striatal Dopaminergic Imaging in Lewy Body Diseases
  44. Pancreatic small cell carcinoma incidentally detected by 18F-FDG-PET/CT
  45. Relationship between prostate-specific antigen kinetics and detection rate of radiolabelled choline PET/CT in restaging prostate cancer patients: a meta-analysis
  46. Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography in the assessment of pleural abnormalities in cancer patients: A systematic review and a meta-analysis
  47. Diagnostic Accuracy of 18F-FDG-PET and PET/CT in the Differential Diagnosis between Malignant and Benign Pleural Lesions
  48. The Role of18F-FDG-PET and PET/CT in Patients with Colorectal Liver Metastases Undergoing Selective Internal Radiation Therapy with Yttrium-90: A First Evidence-Based Review
  49. Diagnostic Performance of Positron Emission Tomography/Computed Tomography Using Fluorine-18 Fluorodeoxyglucose in Detecting Locoregional Nodal Involvement in Patients with Anal Canal Cancer: A Systematic Review and Meta-Analysis
  50. Diagnostic Performance of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in the Postchemotherapy Management of Patients with Seminoma: Systematic Review and Meta-Analysis
  51. Prognostic Significance of Sentinel Lymph Node Mapping in Merkel Cell Carcinoma: Systematic Review and Meta-Analysis of Prognostic Studies
  52. Diagnostic Accuracy of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in the Evaluation of the Primary Tumor in Patients with Cholangiocarcinoma: A Meta-Analysis
  53. Role of PET in Cancer Diagnosis
  54. Prevalence and clinical significance of incidental F18-FDG breast uptake: a systematic review and meta-analysis
  55. Solitary Plasmacytoma of the Sternum Mimicking Bone Metastasis in a Patient with a History of Breast Cancer Evaluated by F-18-FDG PET/CT
  56. Multifocal Extra-Adrenal Paraganglioma Evaluated With Different PET Tracers
  57. Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography for the diagnosis of osteomyelitis related to diabetic foot: A systematic review and a meta-analysis
  58. Splenosis Mimicking Relapse of a Neuroendocrine Tumor at Gallium-68-DOTATOC PET/CT
  59. An Unusual Case of Plasmablastic Lymphoma Presenting as Paravertebral Mass Evaluated by 18 F-FDG PET/CT
  60. Diagnostic Performance of Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography Imaging for Detection of Primary Lesion and Staging of Endometrial Cancer Patients: Systematic Review and Meta-Analysis of the Literature
  61. Incidental 11C-Choline PET/CT Brain Uptake due to Meningioma in a Patient Studied for Prostate Cancer
  62. Small cell carcinoma of the thyroid gland with a solid brain metastasis detected by F-18-FDG PET/CT
  63. Clinical characteristics as predictors of malignancy in patients with indeterminate thyroid cytology: a meta-analysis
  64. Diagnostic Performance of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography Imaging in Uterine Sarcomas
  65. Could 68Ga-somatostatin analogues replace other PET tracers in evaluating extra-adrenal paragangliomas?
  66. Metastatic small cell neuroendocrine carcinoma of the pelvic floor
  67. Toxoplasmic Lymphadenitis Mimicking a Metastatic Thyroid Carcinoma at 18F-FDG-PET/CT
  68. Comparison between whole-body MRI and Fluorine-18-Fluorodeoxyglucose PET or PET/CT in oncology: a systematic review
  69. Is 18F-FDG-PET/CT really able to differentiate between malignant and benign solitary fibrous tumor of the pleura?
  70. Diagnostic Performance of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Patients with Merkel Cell Carcinoma: A Systematic Review and Meta-Analysis
  71. Application of 11C‐acetate positron‐emission tomography (PET) imaging in prostate cancer: systematic review and meta‐analysis of the literature
  72. Markedly Increased 18F-FDG Uptake in a Nonfunctioning Adrenal Adenoma Mimicking Malignancy
  73. Thyroid lobe ablation with iodine-131 in patients with differentiated thyroid carcinoma
  74. Neurofibromatosis
  75. Mycobacteriosis
  76. Sarcoidosis
  77. Inflammatory Bowel Diseases
  78. Usefulness of 18F-FDG PET/CT in syphilitic aortitis
  79. PET imaging using radiolabelled antibodies: future direction in tumor diagnosis and correlate applications
  80. A Rare Case of Ectopic Adrenocorticotropic Hormone Syndrome Caused by a Metastatic Neuroendocrine Tumor of the Pancreas Detected by 68Ga-DOTANOC and 18F-FDG PET/CT
  81. Lymphatic mapping and sentinel node biopsy in squamous cell carcinoma of the vulva: Systematic review and meta-analysis of the literature
  82. Comment on Minamimoto: incidental focal FDG uptake in heart is a lighthouse for considering cardiac screening
  83. A rare case of small cell neuroendocrine carcinoma of the urinary bladder incidentally detected by F-18-FDG PET/CT
  84. When to perform positron emission tomography/computed tomography or radionuclide bone scan in patients with recently diagnosed prostate cancer
  85. 131I whole-body scan or 18FDG PET/CT for patients with elevated thyroglobulin and negative ultrasound?
  86. The role of Fluorine-18-Fluorodeoxyglucose positron emission tomography in staging and restaging of patients with osteosarcoma
  87. Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography in patients with chronic inflammatory bowel disease: A systematic review and a meta-analysis
  88. A Case of Insulinoma Detected by 68Ga-DOTANOC PET/CT and Missed by 18F-Dihydroxyphenylalanine PET/CT
  89. Unusual Muscular Metastases From Papillary Thyroid Carcinoma Detected by Fluorine-18-Fluorodeoxyglucose PET/MRI
  90. Multifocal Head and Neck Paraganglioma Evaluated with Different PET Tracers: Comparison Between Fluorine-18-Fluorodeoxyglucose and Gallium-68-Somatostatin Receptor PET/CT
  91. Factors influencing the sensitivity of 18F-FDG PET/CT in the detection of infective endocarditis
  92. A Rare Case of Primary Thymic Hodgkin Lymphoma in an Elderly Patient Detected by 18F-FDG PET/CT
  93. Masking Effect of Chronic Pancreatitis in the Interpretation of Somatostatin Receptor Positron Emission Tomography in Pancreatic Neuroendocrine Tumors
  94. Recent applications of nuclear medicine in diagnostics: II part
  95. Recent applications of nuclear medicine in diagnostics (I part)
  96. Iodine-131 administration and risk of cancer: “Appearances can be deceptive”
  97. Which is the optimal acquisition time for FDG PET/CT imaging in patients with infective endocarditis?
  98. Pulmonary Neuroendocrine Tumor Incidentally Detected by 18F-CH PET/CT
  99. Usefulness of 18F-FDG PET/CT in Disease Extent and Treatment Response Assessment in a Patient With Syphilitic Aortitis
  100. A Rare Case of Neuroendocrine Tumor of the Middle Ear Detected by Gallium-68-DOTANOC-PET/CT
  101. Diagnostic performance of 99mTc-MIBI scan in predicting the malignancy of thyroid nodules: a meta-analysis
  102. Meta-analyses and systematic reviews on PET and PET/CT in oncology: the state of the art
  103. The role of red blood cell scintigraphy in the multiple-modality imaging diagnosis of a rare case of diffuse hepatic hemangiomatosis in an adult
  104. The role of 18F-FDG PET/CT in the management of large-vessel vasculitis: applications and limitations in clinical practice
  105. Thyroglobulin levels and thyroglobulin doubling time independently predict a positive 18F-FDG PET/CT scan in patients with biochemical recurrence of differentiated thyroid carcinoma
  106. Nodular Nongranulomatous Vasculitis of the Lung Detected by 18F-FDG PET/CT
  107. Diagnostic accuracy of [18F]DOPA PET and PET/CT in patients with neuroendocrine tumors: a meta-analysis
  108. Usefulness of 18F-FDG-PET/CT in Evaluating a Brainstem Glioma in an Adult Patient with Neurofibromatosis Type 1
  109. A standardized dual-phase 18F-DOPA PET/CT protocol in the detection of medullary thyroid cancer
  110. Reply to A standardized dual-phase 18F-DOPA PET/CT protocol in the detection of medullary thyroid cancer by Giorgio Treglia
  111. Accuracy of 18-F-FDG PET imaging in the follow up of endometrial cancer patients: Systematic review and meta-analysis of the literature
  112. A Rare Case of Malignant Granular Cell Tumor of the Colon Incidentally Detected by 18 F-FDG Positron Emission Tomography/Computed Tomography
  113. F18-FDG-PET/CT for evaluation of intraductal papillary mucinous neoplasms (IPMN): a review of the literature
  114. Thyroid Incidentaloma at F-18-FDG Positron Emission Tomography: A Challenge for the Clinicians
  115. Prevalence and Risk of Malignancy of Thyroid Incidentalomas Detected by 18 F-Fluorodeoxyglucose Positron-Emission Tomography
  116. Usefulness of 18F-FDG PET/CT in an Unusual Case of Solid-Pseudopapillary Pancreatic Tumor in Childhood With Aggressive Behavior
  117. The Role of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Aggressive Histological Subtypes of Thyroid Cancer: An Overview
  118. A Comparison between18F-FDG PET/CT Imaging and Biological and Radiological Findings in Restaging of Hepatoblastoma Patients
  119. Staging and treatment response evaluation in a metastatic neuroendocrine tumor of the pancreas with G2 grading: insights from multimodality diagnostic approach by F-18-FDG and Ga-68-DOTANOC PET/CT
  120. 18F-DOPA PET/CT revealed synchronous neuroendocrine tumors in two sisters with MEN2A syndrome
  121. A Papillary Thyroid Tumor Detected by 18F-FDG-PET/CT in a Pediatric Patient with Cowden Syndrome
  122. F18-FDG-PET/CT thyroid incidentalomas: a wide retrospective analysis in three Italian centres on the significance of focal uptake and SUV value
  123. Iodine‐123 Metaiodobenzylguanidine Scintigraphy and Iodine‐123 Ioflupane Single Photon Emission Computed Tomography in Lewy Body Diseases: Complementary or Alternative Techniques?
  124. Usefulness of 18F-FDG PET/CT in Evaluating Disease Activity at Different Times in a Patient With Chronic Periaortitis
  125. Is fluorine-18-fluorodeoxyglucose positron emission tomography useful in monitoring the response to treatment in patients with multiple myeloma?
  126. Emerging role of Fluorine-18-fluorodeoxyglucose positron emission tomography in patients with retroperitoneal fibrosis: a systematic review
  127. Diagnostic and Clinical Significance of F-18-FDG-PET/CT Thyroid Incidentalomas
  128. The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: an overview
  129. Detection Rate of Recurrent Medullary Thyroid Carcinoma Using Fluorine-18 Dihydroxyphenylalanine Positron Emission Tomography
  130. 123I-MIBG Scintigraphy as a Powerful Tool to Plan an Implantable Cardioverter Defibrillator and to Assess Cardiac Resynchronization Therapy in Heart Failure Patients
  131. Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Assessing Retroperitoneal Fibrosis: A Literature Review
  132. The Role of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Assessing the Response to Neoadjuvant Treatment in Patients with Osteosarcoma
  133. Recurrent lymphoma in the thyroid gland detected by fluorine-18-fluorodeoxyglucose PET/CT
  134. Coexistence of Physiologic and Abnormal Muscle Uptake of Fluorine-18-Fluorodeoxyglucose in a Patient with Plasma Cell Leukemia
  135. Comparison of Different Positron Emission Tomography Tracers in Patients with Recurrent Medullary Thyroid Carcinoma: Our Experience and a Review of the Literature
  136. A pooled analysis to calculate the prevalence and risk of malignancy of thyroid incidentalomas detected by Fluorine-18-Fluorodeoxyglucose positron emission tomography.
  137. Diagnostic performance of fluorine-18-dihydroxyphenylalanine positron emission tomography in diagnosing and localizing the focal form of congenital hyperinsulinism: a meta-analysis
  138. The Role of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Evaluating the Response to Treatment in Patients with Multiple Myeloma
  139. Diagnostic performance of planar scintigraphy using 99mTc-MIBI in patients with secondary hyperparathyroidism: a meta-analysis
  140. Diagnostic performance of positron emission tomography using 11C-methionine in patients with suspected parathyroid adenoma: a meta-analysis
  141. PET Imaging in Recurrent Medullary Thyroid Carcinoma
  142. Meta-analysis on MIBG scintigraphy in differential diagnosis between Parkinson's disease and neurodegenerative parkinsonism
  143. Abnormal striatal dopaminergic and cardiac sympathetic imaging in dementia with Lewy bodies: Two sides of the same coin
  144. The role of positron emission tomography using carbon-11 and fluorine-18 choline in tumors other than prostate cancer: a systematic review
  145. 18F-Fluorodeoxyglucose positron emission tomography in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors: a systematic review
  146. 18 F-fluoro-deoxy-glucose focal uptake in very small pulmonary nodules: fact or artifact? Case reports
  147. Further considerations on adverse reactions to radiopharmaceuticals
  148. Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 fluorodeoxyglucose positron emission tomography: a meta-analysis
  149. A Rare Case of Synchronous Bilateral Pulmonary Neuroendocrine Tumor Detected by 68Ga-DOTANOC PET/CT
  150. [18F]FDG-PET/CT in patients affected by retroperitoneal fibrosis: a bicentric experience
  151. Role of PET/CT in the functional imaging of endocrine pancreatic tumors
  152. Ruolo emergente nella pratica clinica della PET con 18F-FDG nei pazienti con sarcoidosi
  153. Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis
  154. Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis
  155. Usefulness of F-18 FDG PET/CT in the Follow-up of POEMS Syndrome After Autologous Peripheral Blood Stem Cell Transplantation
  156. Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma
  157. The emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography in patients with sarcoidosis
  158. Usefulness of Whole-Body Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Patients with Neurofibromatosis Type 1: A Systematic Review
  159. Atypical Presentation of Plasma Cell Leukemia Secondary to Multiple Myeloma Detected by F-18 FDG PET/CT
  160. Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: A systematic review and a meta-analysis
  161. Il contributo della PET/TC con 18F-FDG nelle vasculiti dei grossi vasi: applicazioni e limiti della metodica nella pratica clinica
  162. Diagnostic accuracy of 18 F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis
  163. Usefulness of fluorine-18 fluorodeoxyglucose PET/computed tomography in diagnosis of aortitis and treatment response evaluation in a patient with aortic prosthesis
  164. Un caso raro di angiomatosi epatica diffusa nell’adulto: ruolo della scintigrafia con emazie marcate nell’ambito dell’imaging diagnostico multimodale
  165. 18F-FDG PET Imaging in the Evaluation of Treatment Response to New Chemotherapies beyond Imatinib for Patients with Gastrointestinal Stromal Tumors
  166. Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review
  167. MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis
  168. 123I‐MIBG cardiac scintigraphy in Lewy body–related disorders
  169. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma
  170. Comment on “Incidental focal hypermetabolic colorectal lesions identified by positron emission tomography: prevalence of malignancy”
  171. Is There a Role for Fluorine 18 Fluorodeoxyglucose-Positron Emission Tomography and Positron Emission Tomography/Computed Tomography in Evaluating Patients With Mycobacteriosis? A Systematic Review
  172. Usefulness of MIBG scintigraphy in idiopathic REM sleep behavior disorder: a systematic review
  173. Comparison between18F-Fluorodeoxyglucose Positron Emission Tomography and Sentinel Lymph Node Biopsy for Regional Lymph Nodal Staging in Patients with Melanoma: A Review of the Literature
  174. Diagnostic Performance of Myocardial Innervation Imaging Using MIBG Scintigraphy in Differential Diagnosis between Dementia with Lewy Bodies and Other Dementias: A Systematic Review and a Meta‐Analysis
  175. Nuove applicazioni della medicina nucleare in ambito diagnostico: II parte
  176. Nuove applicazioni della medicina nucleare in ambito diagnostico (I parte)
  177. Recent developments in innervation imaging using iodine-123-metaiodobenzylguanidine scintigraphy in Lewy body diseases
  178. Unusual Increased Metaiodobenzylguanidine Uptake in Liposarcoma
  179. Nuclear medicine procedures in the diagnosis and therapy of medullary thyroid carcinoma
  180. Costal Brown Tumor Detected by Dual-phase Parathyroid Imaging and SPECT-CT in Primary Hyperparathyroidism
  181. Noninvasive adrenal imaging in hyperaldosteronism: is it accurate for correctly identifying patients who should be selected for surgery?